Biodesix, Inc. (BDSX)

NGM – Цена в реальном времени. Валюта: USD

23.34

+3.30 (16.47%)

При закрытии: Jun 26, 2026, 4:00 PM EDT

22.99

-0.35 (-1.50%)

После закрытия: Jun 26, 2026, 7:43 PM EDT

Обзор
Новости
График
Финансы
Дивиденды
Прогноз
Владельцы
Профиль

Biodesix, Inc. (BDSX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Biodesix, Inc. (BDSX)

Are Medical Stocks Lagging Biodesix (BDSX) This Year?

3 Medical Service Industry Stocks Thriving Amid Workforce Challenges

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade

Biodesix to Participate in Upcoming Investor Conferences

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix Announces First Quarter 2026 Results and Highlights

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development

Search stocks

Biodesix, Inc. (BDSX)

Получите доступ ко всем премиум-функциям лучшего инструмента для анализа акций

Finranks

Компания

Контакты

Мы в соцсетях

Biodesix, Inc. (BDSX)

Are Medical Stocks Lagging Biodesix (BDSX) This Year?

3 Medical Service Industry Stocks Thriving Amid Workforce Challenges

Wall Street Analysts Believe Biodesix (BDSX) Could Rally 104.29%: Here's is How to Trade

Biodesix to Participate in Upcoming Investor Conferences

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Does Biodesix (BDSX) Have the Potential to Rally 103.33% as Wall Street Analysts Expect?

Biodesix, Inc. (BDSX) Q1 2026 Earnings Call Transcript

Видео

No Data

Пресс-релизы

Biodesix Announces ATS 2026 Presentations Providing Real-World Clinical Evidence and Healthcare System Economic Value for Nodify Lung® Testing Strategy

Biodesix Announces First Quarter 2026 Results and Highlights

Biodesix Recognized as a Top Workplace for Third Consecutive Year

Biodesix Announces AACR 2026 Posters and Presentations, Highlighting Novel Diagnostic Test Discovery & Pipeline Development